IBDQ (iShares iBonds Dec 2025 Term Corporate ETF) Stock Analysis - Politician Trades
iShares iBonds Dec 2025 Term Corporate ETF (IBDQ) is a publicly traded the market company. As of May 21, 2026, IBDQ trades at $25.12 with a market cap of $0 and a P/E ratio of 0.00. IBDQ moved -0.08% today. Year to date, IBDQ is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBDQ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded IBDQ stock?
Recent politician trading activity in IBDQ includes disclosures from Lindsey Graham. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
IBDQ Key Metrics
Key financial metrics for IBDQ
Metric
Value
Price
$25.12
Market Cap
$0
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$0.00
52-Week Low
$0.00
Volume
855.45K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Congressional Trades in IBDQ
Lindsey Graham purchase IBDQ on Jun 30, 2022 (amount: $50.00K) for Self.
IBDQ Analyst Consensus
IBDQ analyst coverage data. Average price target: $0.00.
Common questions about IBDQ
Which politicians traded IBDQ stock?
Recent politician trading activity in IBDQ includes disclosures from Lindsey Graham. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in IBDQ?
Yes. Rallies tracks politician and congressional stock disclosures for IBDQ, including reported purchases, sales, dates, owners, and trade amounts when available.
Is IBDQ research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBDQ. It does not provide personalized investment advice.
